Bellus Health Inc. [BLU]

Source: 

Company Overview

Bellus Health Inc. is a clinical-stage biopharmaceutical company working to better the  lives of patients suffering from persistent cough, starting with the development of camlipixant for the treatment of RCC. It has been 6 decades since the last treatment was approved for cough in the U.S. and currently, there are no approved treatments available in the U.S. for patients suffering from RCC.